Pertuzumab is a prescription used to treat certain types of breast cancer. It is a type of monoclonal antibody. Monoclonal antibodies are man-made proteins that mimic the antibodies found in the body. Pertuzumab works by binding to a protein called HER2 on the surface of cancer cells. This helps to block the growth and spread of cancer cells.
Pertuzumab is given as an intravenous (IV) infusion. The infusion is usually given over a period of 60 minutes.
The usual starting dose is 420 mg, followed by 210 mg every 3 weeks
Pertuzumab injection is available in two strengths, 150 mg/mL and 420 mg/mL. The 150 mg/mL strength is available in single-dose vials, and the 420 mg/mL strength is available in single-dose and multi-dose vials. The average wholesale price (AWP) for a single-dose vial of pertuzumab 150 mg/mL is $3,285.00, and the AWP for a single-dose vial of pertuzumab 420 mg/mL is $9,855.00. The average wholesale price for a multi-dose vial of pertuzumab 420 mg/mL is $14,280.00.
Common side effects of pertuzumab Injection include
Common side effects of pertuzumab Injection include fatigue, nausea, diarrhea, headache, and infusion-related reactions. Fatigue is the most common side effect, and may persist for weeks or months after treatment. Firstly, Nausea and diarrhea are also common, and may be managed with medications. Headache and infusion-related reactions are usually mild and go away on their own.
Therefore, Pertuzumab can also cause more serious side effects, such as heart problems, lung problems, and allergic reactions. These side effects are rare, but can be life-threatening. If you experience any of these side effects, call your doctor immediately.
Pertuzumab is generally well-tolerated, but like all medications, it has the potential for side effects. Be sure to talk to your doctor about all the risks and benefits of pertuzumab before starting treatment.
Read More:- Click Here